IMCR — Immunocore Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapNeutral

Annual balance sheet for Immunocore Holdings, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	10-K	10-K	10-K	10-K
Standards:	IFRS	USG	USG	USG	USG
Status:	fx Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	322	402	443	820	864
Net Total Accounts Receivable
Net Total Receivables	23.2	57.1	61.4	83.1	101
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	355	474	529	930	997
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	42.7	38.8	42.7	47.7	50.2
Long Term Investments
Other Long Term Assets
Total Assets	408	527	597	1,010	1,067
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	82.8	101	139	212	247
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	176	188	228	649	686
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	232	339	369	361	381
Total Liabilities & Shareholders' Equity	408	527	597	1,010	1,067
Total Common Shares Outstanding